Ethanol extract from birch bark (Betula pubescens) suppresses human dendritic cell mediated Th1 responses and directs it towards a Th17 regulatory response in vitro.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Freysdottir, JonaSigurpalsson, Marino Boas
Omarsdottir, Sesselja
Olafsdottir, Elin S
Vikingsson, Arnor
Hardardottir, Ingibjorg
Issue Date
2011-04-30
Metadata
Show full item recordCitation
Immunol. Lett. 2011, 136(1):90-6Abstract
Extracts and fractions from birch bark have been used to treat various diseases, such as skin disorders and rheumatism, and for analgesic effects. Results from studies in vitro and in vivo have shown that birch bark extracts can have immunoregulatory effects. These effects have mainly been attributed to the various triterpenes found in birch bark. The effects of birch bark from Betula pubescens on immune responses have not been reported. Ethanol extract was prepared from dry birch bark (DBBEE) and five fractions made using various ratios of dichloromethane and methanol (fractions I-V). Human monocyte-derived dendritic cells (DCs) were matured with or without DBBEE or fractions I-V at several concentrations. The effects of the extract and fractions on DC maturation were determined by measuring cytokine secretion by ELISA and expression of surface molecules by flow cytometry. DBBEE and fractions III and IV reduced DC secretion of IL-6, IL-10 and IL-12p40 and expression of CD83, CD86, CCR7 and DC-SIGN compared with control DCs. Proliferation of allogeneic CD4(+) T cells co-cultured with DCs matured with fraction IV, as measured by (3)H-thymidine incorporation, was similar to proliferation of allogeneic CD4(+) T cells co-cultured with control DCs. However, IFN-γ secretion was reduced and IL-10 and IL-17 secretion was increased, a cytokine profile consistent with a Th17 regulatory phenotype. These results indicate that bark from Betula pubescens contains compound(s) that can modulate DCs so that their interaction with T cells leads to an immunoregulatory response.Description
To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldAdditional Links
http://dx.doi.org/10.1016/j.imlet.2010.12.009ae974a485f413a2113503eed53cd6c53
10.1016/j.imlet.2010.12.009
Scopus Count
Collections
Related articles
- Loxoribine, a selective Toll-like receptor 7 agonist, induces maturation of human monocyte-derived dendritic cells and stimulates their Th-1- and Th-17-polarizing capability.
- Authors: Dzopalic T, Dragicevic A, Vasilijic S, Vucevic D, Majstorovic I, Bozic B, Balint B, Colic M
- Issue date: 2010 Nov
- Immunomodulatory effects of aqueous birch pollen extracts and phytoprostanes on primary immune responses in vivo.
- Authors: Gutermuth J, Bewersdorff M, Traidl-Hoffmann C, Ring J, Mueller MJ, Behrendt H, Jakob T
- Issue date: 2007 Aug
- Aqueous extracts from Menyanthes trifoliate and Achillea millefolium affect maturation of human dendritic cells and their activation of allogeneic CD4+ T cells in vitro.
- Authors: Jonsdottir G, Omarsdottir S, Vikingsson A, Hardardottir I, Freysdottir J
- Issue date: 2011 Jun 14
- Impaired maturation of monocyte-derived dendritic cells from birch allergic individuals in association with birch-specific immune responses.
- Authors: Casas R, Skarsvik S, Lindström A, Zetterström O, Duchén K
- Issue date: 2007 Nov
- Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season.
- Authors: Grindebacke H, Wing K, Andersson AC, Suri-Payer E, Rak S, Rudin A
- Issue date: 2004 Sep